These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 32295037)
1. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach. Joshi PR; Zierz S Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037 [TBL] [Abstract][Full Text] [Related]
2. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features. Lehmann D; Motlagh L; Robaa D; Zierz S Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946 [TBL] [Abstract][Full Text] [Related]
3. Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency. Lehmann D; Zierz S J Neurol Sci; 2014 Apr; 339(1-2):183-8. PubMed ID: 24602495 [TBL] [Abstract][Full Text] [Related]
4. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs. Schmidt I; Herpin P J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999 [TBL] [Abstract][Full Text] [Related]
5. Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Zierz S; Engel AG Eur J Biochem; 1985 May; 149(1):207-14. PubMed ID: 3996401 [TBL] [Abstract][Full Text] [Related]
7. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids. Brady LJ; Brady PS; Gandour RD Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937 [TBL] [Abstract][Full Text] [Related]
8. Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation. Kashfi K; Mynatt RL; Cook GA Biochim Biophys Acta; 1994 May; 1212(2):245-52. PubMed ID: 8180250 [TBL] [Abstract][Full Text] [Related]
9. Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency. Zierz S Clin Investig; 1994 Dec; 72(12):957-60. PubMed ID: 7711426 [TBL] [Abstract][Full Text] [Related]
10. Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency. Motlagh Scholle L; Lehmann D; Joshi PR; Zierz S Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897730 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A. Zierz S; Neumann-Schmidt S; Jerusalem F Clin Investig; 1993 Oct; 71(10):763-9. PubMed ID: 8305830 [TBL] [Abstract][Full Text] [Related]
12. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients. Joshi PR; Deschauer M; Zierz S J Neurol Sci; 2014 Mar; 338(1-2):107-11. PubMed ID: 24398345 [TBL] [Abstract][Full Text] [Related]
13. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Stanley CA Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency. Yasuno T; Osafune K; Sakurai H; Asaka I; Tanaka A; Yamaguchi S; Yamada K; Hitomi H; Arai S; Kurose Y; Higaki Y; Sudo M; Ando S; Nakashima H; Saito T; Kaneoka H Biochem Biophys Res Commun; 2014 May; 448(2):175-81. PubMed ID: 24780397 [TBL] [Abstract][Full Text] [Related]
15. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665 [TBL] [Abstract][Full Text] [Related]
16. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I. Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates. Smith BK; Perry CG; Koves TR; Wright DC; Smith JC; Neufer PD; Muoio DM; Holloway GP Biochem J; 2012 Nov; 448(1):13-20. PubMed ID: 22928974 [TBL] [Abstract][Full Text] [Related]
18. Carnitine acyltransferases in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency. Neumann-Schmidt S; Zierz S Neuromuscul Disord; 1991; 1(4):253-60. PubMed ID: 1822803 [TBL] [Abstract][Full Text] [Related]
19. Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient. Cho SY; Siu TS; Ma O; Tam S; Lam CW Clin Chim Acta; 2013 Oct; 425():125-7. PubMed ID: 23911907 [TBL] [Abstract][Full Text] [Related]
20. Myopathy due to carnitine palmitoyltransferase II deficiency: updating genetic aspects of the first publication in Brazil. Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Rodrigues PRDVP; Arndt RC; Scola RH; Werneck LC Arq Neuropsiquiatr; 2024 Feb; 82(2):1-4. PubMed ID: 38395422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]